Medication info
Ezirol Tablet (Ezetimibe)

Ezirol Tablet (Ezetimibe)

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White to nearly white rectangular tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201902285 · Approved 2019.04.15 · Insurance code 670608990

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued while taking this medication. The recommended dose of this medication is 10 mg once daily, with or without food. When this medication is coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate treatment with this medication together with the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medication concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medication is coadministered with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Use with Caution in the Following Patients). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary in elderly patients. Administer this medication at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • dyslipidemia
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
  • decreased high-density lipoprotein cholesterol
  • increased triglycerides
View approved original text

This drug is used as an adjunct to dietary therapy to reduce cholesterol and apolipoprotein levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is particularly effective in patients with heterozygous familial hypercholesterolemia and can be administered in combination with HMG-CoA reductase inhibitors or fenofibrate if necessary. In patients with homozygous familial hypercholesterolemia, it is used in combination with statins when other lipid-lowering treatments are inadequate or when monotherapy is not possible. Additionally, this drug is used as an adjunct in dietary therapy to lower plant sterol levels in patients with homozygous sitosterolemia. This medication should be used in conjunction with appropriate dietary measures and non-pharmacological approaches, and it is important to exclude and treat secondary causes of dyslipidemia if necessary. Thus, this drug effectively improves various forms of cholesterol and lipid abnormalities associated with dyslipidemia.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued while taking this medication. The recommended dose of this medication is 10 mg once daily, with or without food. When this medication is coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate treatment with this medication together with the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medication concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medication is coadministered with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Use with Caution in the Following Patients). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary in elderly patients. Administer this medication at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Precautions

This medication should not be used by patients with allergies to specific ingredients. Patients with active liver disease or persistent liver dysfunction should not take this medication along with other specific lipid-lowering agents. Women who are pregnant or breastfeeding should use caution as concomitant use with certain lipid-lowering drugs is prohibited. This drug is not recommended for patients with moderate to severe liver impairment and should be used with caution in such cases. While taking this medication, symptoms such as headache, abdominal pain, diarrhea, fatigue, and myalgia may occur, and if unusual symptoms arise, consultation with a physician is advised. If symptoms such as myalgia or muscle weakness occur, medical professionals should be notified immediately, and medication may be discontinued if necessary. Patients with severe renal impairment do not require dosage adjustment for this drug, but it is important to periodically check renal function status. There may be interactions with other medications, so it is important to inform the physician if taking cholestyramine, fibrates, cyclosporine, anticoagulants, etc. Pregnant or breastfeeding women should carefully consider the potential risks and benefits of using this medication and avoid use if possible. This medication is not recommended for children under 6 years of age and should be administered to children and adolescents aged 6 years and over under the direction of a physician. Elderly patients can also use this drug, but careful observation should be exercised considering age-related sensitivity differences. When storing the medication, it should be kept out of reach of children and not transferred to other containers.

Side effects

  • fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • chest pain
Show 64 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevated AST
  • elevated ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • sensory abnormalities
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • drug-induced liver injury
  • chest discomfort
  • chest unease
  • edema
  • asthenia
  • systemic edema
  • diabetic neuropathy
  • tremor
  • epigastric pain
  • vomiting
  • gastritis
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • rhinorrhea
  • limb pain
  • diabetes mellitus
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • rash
  • pruritus
  • upper respiratory infection
  • conjunctival hyperemia
  • renal failure
  • liver dysfunction
  • elevated serum creatinine
  • increased blood pressure
  • elevated blood urea
  • increased serum creatine phosphokinase
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is best to keep the medication at room temperature between 1°C and 30°C, avoiding excessively hot or cold places. Proper storage will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

White to nearly white rectangular tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.